biosimilars

July 16, 2015July 23, 2015

More Research Needed To Effectively Treat Children With IBD Using Biosimilars

News

Children suffering from inflammatory bowel disease (IBD) who are reacting positively to prescribed biological medications should not have their prescriptions changed to recently approved “biosimilar” products, according to the results of an expert consensus statement ... Read more

June 8, 2015June 8, 2015

First Infliximab Biosimilar Approved in Brazil For Crohn’s Disease

Crohn's Disease, News

The National Health Surveillance Agency (ANVISA) in Brazil has approved the commercialization of Remsima (infliximab), indicated for a series of conditions such as Crohn’s disease and ulcerative colitis, making it the first ... Read more

March 19, 2015March 19, 2015

Samsung Submits MAA for Remicade Biosimilar For Crohn’s Disease, Ulcerative Colitis to EMA

Crohn's Disease, News, Ulcerative colitis

Samsung Bioepis Co. Ltd. recently submitted a Marketing Authorization Application (MAA) to the European Medicines Agency (EMA) regarding a biosimilar treatment for several conditions, including Crohn’s disease and ulcerative colitis. The Remicade (Infliximab) ... Read more

January 2, 2015January 2, 2015

Torrent Pharma and Reliance Life Sciences Partner to Market IBD Biosimilars

IBD News, News

Torrent Pharmaceuticals Ltd. has signed a licensing agreement with Reliance Life Sciences for the marketing of three biosimilar products in India. The two companies are planning to market the biosimilars adalimumab, a treatment for ... Read more